Dover Corporation Peer Comparison
Metric | Value | Ranking | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $25.6 Billion | 8/11 | ETN $117.1B |
ITW $72.8B |
PH $70.1B |
EMR $65.6B |
IR $39.1B |
CMI $38.7B |
XYL $33.2B |
DOV $25.6B |
PNR $14.3B |
AOS $12.1B |
FELE $4.8B |
Gross Margin | 37% | 5/11 | ITW 46% |
IR 45% |
AOS 39% |
PNR 38% |
DOV 37% |
ETN 37% |
PH 35% |
FELE 35% |
CMI 24% |
XYL 0% |
EMR -23% |
Profit Margin | 30% | 1/11 | DOV 30% |
CMI 24% |
ITW 21% |
AOS 15% |
ETN 14% |
PH 14% |
PNR 13% |
IR 12% |
EMR 11% |
FELE 7% |
XYL 0% |
EBITDA margin | 19% | 6/11 | ITW 31% |
PH 24% |
PNR 23% |
AOS 22% |
ETN 21% |
DOV 19% |
IR 18% |
FELE 14% |
CMI 13% |
EMR -43% |
XYL -100% |
Quarterly Revenue | $2.1 Billion | 6/11 | CMI $8.4B |
ETN $5.9B |
PH $5.1B |
EMR $4.4B |
ITW $4.0B |
DOV $2.1B |
IR $1.7B |
PNR $1.0B |
AOS $978.8M |
FELE $460.9M |
XYL $0 |
Quarterly Earnings | $632.2 Million | 5/11 | CMI $2.0B |
ETN $821.0M |
ITW $819.0M |
PH $726.6M |
DOV $632.2M |
EMR $501.0M |
IR $202.2M |
XYL $153.0M |
AOS $147.6M |
PNR $133.3M |
FELE $33.0M |
Quarterly Free Cash Flow | $122.1 Million | 5/11 | PH $715.9M |
EMR $661.0M |
ITW $494.0M |
ETN $292.0M |
DOV $122.1M |
CMI $107.0M |
IR $99.3M |
AOS $84.6M |
XYL $15.0M |
FELE -$10.5M |
PNR -$126.9M |
Trailing 4 Quarters Revenue | $8.5 Billion | 6/11 | CMI $34.0B |
ETN $23.7B |
PH $19.8B |
EMR $16.5B |
ITW $16.1B |
DOV $8.5B |
IR $6.9B |
XYL $5.9B |
PNR $4.1B |
AOS $3.9B |
FELE $2.0B |
Trailing 4 Quarters Earnings | $1.5 Billion | 6/11 | CMI $8.4B |
ETN $5.9B |
PH $5.1B |
EMR $4.4B |
ITW $4.0B |
DOV $2.1B |
IR $1.7B |
PNR $1.0B |
AOS $978.8M |
FELE $460.9M |
XYL -$0 |
Quarterly Earnings Growth | 177% | 1/11 | DOV 177% |
CMI 152% |
XYL 55% |
ETN 29% |
IR 26% |
PH 23% |
AOS 16% |
ITW 15% |
PNR 3% |
EMR -1% |
FELE -12% |
Annual Earnings Growth | 43% | 5/11 | EMR 626% |
AOS 347% |
PH 56% |
PNR 51% |
DOV 43% |
ETN 21% |
XYL 21% |
FELE 21% |
IR 1% |
ITW -11% |
CMI -28% |
Quarterly Revenue Growth | 1% | 4/11 | EMR 17% |
ETN 8% |
IR 3% |
DOV 1% |
AOS 1% |
PH 0% |
CMI -1% |
ITW -1% |
PNR -1% |
FELE -5% |
XYL -100% |
Annual Revenue Growth | -1% | 10/11 | EMR 19% |
ETN 9% |
CMI 7% |
IR 6% |
FELE 5% |
PH 4% |
AOS 2% |
ITW 1% |
PNR 1% |
DOV -1% |
XYL -1% |
Cash On Hand | $930.0 Million | 6/11 | CMI $2.5B |
EMR $2.3B |
IR $1.5B |
ITW $959.0M |
XYL $947.0M |
DOV $930.0M |
ETN $473.0M |
PH $405.5M |
AOS $251.6M |
PNR $109.1M |
FELE $65.3M |
Short Term Debt | $969.0 Million | 6/11 | PH $4.1B |
EMR $3.3B |
ITW $2.1B |
CMI $1.2B |
ETN $995.0M |
DOV $969.0M |
XYL $285.0M |
IR $73.8M |
FELE $42.4M |
PNR $25.9M |
AOS $10.0M |
Long Term Debt | $3.0 Billion | 6/11 | ETN $8.8B |
EMR $7.6B |
PH $7.3B |
ITW $6.3B |
CMI $5.6B |
DOV $3.0B |
IR $2.7B |
PNR $2.1B |
XYL $2.0B |
FELE $129.0M |
AOS $109.7M |
PE | 17.53 | 10/11 | XYL 50.15 |
IR 47.71 |
ETN 34.42 |
PH 25.31 |
FELE 25.23 |
ITW 23.76 |
PNR 22.75 |
AOS 20.88 |
CMI 19.99 |
DOV 17.53 |
EMR 6.11 |
PS | 3.03 | 9/11 | IR 5.65 |
XYL 5.62 |
ETN 4.95 |
ITW 4.53 |
EMR 3.97 |
PH 3.53 |
PNR 3.48 |
AOS 3.12 |
DOV 3.03 |
FELE 2.34 |
CMI 1.14 |
PB | 4.97 | 5/11 | ITW 24.08 |
AOS 6.41 |
ETN 6.06 |
PH 6.04 |
DOV 4.97 |
PNR 4.28 |
IR 3.94 |
FELE 3.91 |
CMI 3.83 |
XYL 3.26 |
EMR 2.45 |
PC | 27.53 | 9/11 | ETN 247.55 |
PH 172.81 |
PNR 130.62 |
ITW 75.87 |
FELE 73.20 |
AOS 47.91 |
XYL 35.11 |
EMR 28.28 |
DOV 27.53 |
IR 26.93 |
CMI 15.24 |
Liabilities to Equity | 1.33 | 4/11 | ITW 4.18 |
CMI 2.40 |
PH 1.55 |
DOV 1.33 |
PNR 1.03 |
ETN 1.00 |
EMR 0.94 |
AOS 0.69 |
IR 0.57 |
XYL 0.56 |
FELE 0.45 |
ROA | 0.12 | 4/11 | EMR 23% | ITW 20% | AOS 18% | DOV 12% | FELE 11% | ETN 9% | PNR 9% | PH 9% | CMI 6% | IR 5% | XYL 4% |
ROE | 0.28 | 4/11 | ITW 101% |
EMR 51% |
AOS 31% |
DOV 28% |
PH 24% |
CMI 21% |
PNR 19% |
ETN 18% |
FELE 16% |
IR 8% |
XYL 7% |
Current Ratio | 1.75 | 8/11 | FELE 3.23 |
XYL 2.78 |
IR 2.77 |
AOS 2.45 |
EMR 2.36 |
ETN 2.01 |
PNR 1.98 |
DOV 1.75 |
PH 1.65 |
CMI 1.46 |
ITW 1.24 |
Quick Ratio | 0.14 | 4/11 | XYL 50.15 |
IR 47.71 |
ETN 34.42 |
PH 25.31 |
FELE 25.23 |
ITW 23.76 |
PNR 22.75 |
AOS 20.88 |
CMI 19.99 |
DOV 17.53 |
EMR 6.11 |
Long Term Debt to Equity | 0.58 | 5/11 | ITW} 2.07 |
PNR} 0.63 |
PH} 0.63 |
CMI} 0.62 |
DOV} 0.58 |
ETN} 0.46 |
EMR} 0.36 |
IR} 0.27 |
XYL} 0.19 |
FELE} 0.11 |
AOS} 0.06 |
Debt to Equity | 0.77 | 4/11 | ITW 2.76 |
PH 0.98 |
CMI 0.80 |
DOV 0.77 |
PNR 0.66 |
EMR 0.55 |
ETN 0.51 |
IR 0.28 |
XYL 0.22 |
FELE 0.14 |
AOS 0.08 |
Burn Rate | -3.43 | 7/11 | EMR 3.67 |
PH 0.69 |
CMI -1.73 |
AOS -1.79 |
ETN -2.14 |
PNR -2.51 |
DOV -3.43 |
FELE -3.80 |
ITW -18.39 |
IR -19.04 |
XYL -402.98 |
Cash to Cap | 0.04 | 2/11 | CMI 0.07 |
DOV 0.04 |
EMR 0.04 |
IR 0.04 |
XYL 0.03 |
AOS 0.02 |
ITW 0.01 |
PNR 0.01 |
PH 0.01 |
FELE 0.01 |
ETN 0.00 |
CCR | 0.19 | 7/11 | EMR 1.32 |
PH 0.99 |
ITW 0.60 |
AOS 0.57 |
IR 0.49 |
ETN 0.36 |
DOV 0.19 |
XYL 0.10 |
CMI 0.05 |
FELE -0.32 |
PNR -0.95 |
EV to EBITDA | 72.00 | 5/11 | XYL} 225.95 |
IR} 137.85 |
ETN} 100.64 |
FELE} 78.27 |
DOV} 72.00 |
PNR} 70.71 |
PH} 65.68 |
ITW} 64.62 |
AOS} 56.49 |
CMI} 40.79 |
EMR} -40.13 |
EV to Revenue | 3.39 | 8/11 | IR 5.84 |
XYL 5.84 |
ETN 5.34 |
ITW 4.99 |
EMR 4.52 |
PH 4.08 |
PNR 3.99 |
DOV 3.39 |
AOS 3.09 |
FELE 2.39 |
CMI 1.28 |